Cohance Lifesciences Appoints Abhimanyu Ojha as Chief Financial Officer
Cohance Lifesciences Ltd 路 Change in Management 路 10 Oct 2026, 1:54 am
Cohance Lifesciences Appoints Abhimanyu Ojha as Chief Financial Officer Cohance Lifesciences Limited (formerly Suven Pharmaceuticals) has approved the appointment of Abhimanyu Ojha as Chief Financial Officer and Key Managerial Personnel, effective 12th Oct'26. Ojha brings over two decades of pharma and healthcare leadership experience, having previously served as Global CFO & President Finance at Intas Pharmaceuticals, along with senior leadership roles at Viatris, Sun Pharmaceuticals, and Ranbaxy Laboratories. He will also join the authorized Key Managerial Personnel panel alongside Chairman & Group CEO Umang Vohra to determine and disclose material events.
Original exchange filing (PDF)
More announcements from Cohance Lifesciences Ltd
- The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasti Property and Equity Holdings .... 路 12 Nov 2026
- The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasub Property Holdings LLP & Others 路 12 Nov 2026
- Investors Meet 路 11 Nov 2026
- Transcript of Con call 路 11 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasub Property Holdings LLP & Others 路 11 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasti Property and Equity Holdings Pvt Ltd & Others 路 11 Nov 2026
- Investor Presentation 路 07 Nov 2026
- Update on USFDA inspection at Pashamylaram Manufacturing facility. 路 07 Nov 2026
